U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473700) titled 'Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease' on Feb. 27.
Brief Summary: The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.
Study Start Date: March 30
Study Type: INTERVENTIONAL
Condition:
Hypertension, Pulmonary
Lung Diseases, Interstitial
Intervention:
DRUG: TX000045
Subcutaneous Injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tecto...